Beneficial Effect of Isoniazid Preventive Therapy and Antiretroviral Therapy on the Incidence of Tuberculosis in People Living with HIV in Ethiopia

• Kesetebirhan Delele Yirdaw ,

  * E-mail: kcgp2005@yahoo.com

  Affiliation Clinical Department, Johns Hopkins University TSEHAI Project, Addis Ababa, Ethiopia

  ⨯
• Degu Jerene,

  Affiliation Clinical Department, Johns Hopkins University TSEHAI Project, Addis Ababa, Ethiopia

  ⨯
• Zewdu Gashu,

  Affiliation Clinical Department, Johns Hopkins University TSEHAI Project, Addis Ababa, Ethiopia

  ⨯
• M. E. Edginton,

  Affiliation Center for Operational Research, International Union against Tuberculosis and Lung Disease, Paris, France

  ⨯
• Ajay M. V. Kumar,

  Affiliation International Union against Tuberculosis and Lung Disease, South-East Asia Regional Office, New Delhi, India

  ⨯
• Yohannes Letamo,

  Affiliation Health Research and Technology Transfer Support Process, Southern Nations Nationalities and People's Region Health Bureau, Hawassa, Southern Nations Nationalities and People's Region, Ethiopia

  ⨯
• Beniam Feleke,

  Affiliation Care and treatment branch, TB/HIV unit, Centers for Disease Control and Prevention, Addis Ababa, Ethiopia

  ⨯
• Alula M. Teklu,

  Affiliation PCM Department, Johns Hopkins University TSEHAI Project, Addis Ababa, Ethiopia

  ⨯
• Solomon Zewdu,

  Affiliation Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Bill Weiss,

  Affiliation Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Andrea Ruff

  Affiliation Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯